TY - JOUR
T1 - The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks' gestational age
AU - Doering, Gunther
AU - Gusenleitner, Walter
AU - Belohradsky, Bernd H.
AU - Burdach, Stefan
AU - Resch, Bernhard
AU - Liese, Johannes G.
N1 - Funding Information:
The study was supported by an unrestricted grant from Abbott Laboratories, Germany. G. Doering, J. G. Liese, and B. Resch participate in advisory board meetings concerning the “RSV Risk Assessment,” sponsored by Abbott Int.
PY - 2006/12
Y1 - 2006/12
N2 - Among 1158 preterm infants of 29-35 weeks' gestational age, respiratory syncytial virus (RSV) -related hospitalizations (RSV-H) occurred in 4.2% during the first year of life. Four independent factors influenced the risk for RSV-H: neurologic problems (odds ratio [OR], 3.6), male gender (OR, 2.8), presence of an older sibling (OR, 1.7) and discharge from October to December (OR, 1.7). The estimated risk of RSV-H varied between 1% (no risk factor present) and 30% (4 risk factors present).
AB - Among 1158 preterm infants of 29-35 weeks' gestational age, respiratory syncytial virus (RSV) -related hospitalizations (RSV-H) occurred in 4.2% during the first year of life. Four independent factors influenced the risk for RSV-H: neurologic problems (odds ratio [OR], 3.6), male gender (OR, 2.8), presence of an older sibling (OR, 1.7) and discharge from October to December (OR, 1.7). The estimated risk of RSV-H varied between 1% (no risk factor present) and 30% (4 risk factors present).
KW - Multivariate logistic regression
KW - Palivizumab
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=33845402958&partnerID=8YFLogxK
U2 - 10.1097/01.inf.0000246978.58565.b5
DO - 10.1097/01.inf.0000246978.58565.b5
M3 - Article
C2 - 17133170
AN - SCOPUS:33845402958
SN - 0891-3668
VL - 25
SP - 1188
EP - 1190
JO - Pediatric Infectious Disease Journal
JF - Pediatric Infectious Disease Journal
IS - 12
ER -